Although the company remains quiet about the project, this patent—filed with the United States Patent and Trademark Office (USPTO)—gives some clues as to Samsung’s vision for this next-generation ...
Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...
edatanetworks Inc. announced today the approval of patent 18/385,505 from the United States Patent and Trademark Office (USPTO). This patent further strengthens edatanetworks' intellectual property ...
An application for a comparable U.S. patent has been submitted to the United States Patent and Trademark Office, and is currently under review. "Molecularly targeted therapies are effective ...